focus -WSS

focus

author：entertainment 2025-09-30 22:05:24 - browse：695

Coronary medical stent -- health business coverage from STAT — Adobe

Coronary stenting is, by some measures, the most overused procedure in hospitals. The problem costs the health system millions and unnecessarily exposes patients to risks of blood clots, torn arteries, infections, and other life-threatening injuries.

In 2020, Medicare started paying physicians to place stents, balloons, and perform other procedures designed to open clogged coronary arteries outside of hospitals, in less expensive outpatient settings. It didn’t take long for private equity firms to catch on. They’ve been racing to buy up cardiology practices ever since, rolling them into bigger and bigger chains with an eye toward reselling them at a profit.

It’s similar to what happened with orthopedics and gastroenterology, two specialties that have become saturated with private equity money since more procedures went outpatient. Research in other specialties has shown that these financial investors tend to usher in more patients, ramp up surgeries, and jack up prices, effectively increasing spending even as government policies try to lower it. Now, experts say they fear the same thing could happen in cardiology, a field with a long track record of overuse.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： American taxpayers paid $1.8 trillion in health care costs in 2022

Wikipedia

WSS

WATCH: Why do bright lights make us see spots?

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Hospital chaplains balance Covid safety with patients’ spiritual needs

IRA could hurt research into orphan drugs for rare diseases

What to make of Biden’s latest efforts on cancer research

How to make the FDA’s new prescription one

hotspot

focus

Wikipedia

Novavax promises a turnaround & Lilly roils the obesity market

Study suggests new cause of Down syndrome: cells linked to aging

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Pig kidney works a record two months in donated body

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Hepatitis C has a cure — but many Americans still lack access to it

Private equity could exacerbate cardiology's overuse problem, experts fear

Trump demands the U.S. pay no more for drugs than other countries … again

Study suggests new cause of Down syndrome: cells linked to aging

knowledge

A preacher's new calling: Diversifying neuroscience research

Study suggests new cause of Down syndrome: cells linked to aging

WATCH: Why do bright lights make us see spots?

Study suggests new cause of Down syndrome: cells linked to aging

Regeneron agrees to White House price limits on anti

What to make of Biden’s latest efforts on cancer research

hotspot

Wikipedia

Wikipedia

knowledge